Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone during cement implantation in knee replacement
IRCT20180528039883N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of hydrocortisone in bone cement implantation syndrome (BCIS) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Heart rate, Blood pressure and 6 more. Started Jun 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
bone cement implantation syndrome (BCIS)
Beyond the preview
Go deeper on IRCT20180528039883N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180528039883N3.